138 related articles for article (PubMed ID: 9588575)
41. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
Di Chiro G
Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
[No Abstract] [Full Text] [Related]
42. [Changes in the (11C-methyl)-L-methionine uptake index in gliomas following radiotherapy].
Mineura K; Sasajima T; Kowada M; Shishido F; Uemura K
Gan No Rinsho; 1989 Sep; 35(10):1101-4. PubMed ID: 2789298
[TBL] [Abstract][Full Text] [Related]
43. [Sequential CT findings in low-density non-enhancing gliomas].
Maeda T; Okada J; Takeuchi K
Neurol Med Chir (Tokyo); 1984 Nov; 24(11):863-8. PubMed ID: 6084193
[No Abstract] [Full Text] [Related]
44. Methionine transport in brain tumors.
O'Tuama LA
J Neuropsychiatry Clin Neurosci; 1989; 1(1):S37-44. PubMed ID: 2535419
[No Abstract] [Full Text] [Related]
45. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
46. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
47. [The role of PET-FDG in questionable diagnosis of relapse in the presence of radionecrosis of brain tumors].
Asensio C; Pérez-Castejón MJ; Maldonado A; Montz R; Ruiz JA; Santos M; García-Berrocal I; Albert J; Carreras JL
Rev Neurol; 1998 Sep; 27(157):447-52. PubMed ID: 9774817
[TBL] [Abstract][Full Text] [Related]
48. Recurrent oligodendroglioma diagnosed with 11C-L-methionine and PET: a case report.
Viader F; Derlon JM; Petit-Taboué MC; Shishido F; Hubert P; Houtteville JP; Courtheoux P; Chapon F
Eur Neurol; 1993; 33(3):248-51. PubMed ID: 8467848
[TBL] [Abstract][Full Text] [Related]
49. Positron emission tomography-guided stereotactic brain biopsy.
Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
[TBL] [Abstract][Full Text] [Related]
50. [Value of 11C-methionine and PET in the diagnosis of low grade gliomas].
Shishido F; Uemura K; Inugami A; Tomura N; Higano S; Fujita H; Murakami M; Kanno I; Yasui N; Mineura K
Kaku Igaku; 1990 Apr; 27(4):293-302. PubMed ID: 2376915
[TBL] [Abstract][Full Text] [Related]
51. Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies.
Le Roux PD; Berger MS; Wang K; Mack LA; Ojemann GA
J Neurooncol; 1992 Jun; 13(2):189-98. PubMed ID: 1432034
[TBL] [Abstract][Full Text] [Related]
52. Imaging of low- and intermediate-grade gliomas.
Ricci PE; Dungan DH
Semin Radiat Oncol; 2001 Apr; 11(2):103-12. PubMed ID: 11285548
[TBL] [Abstract][Full Text] [Related]
53. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
[TBL] [Abstract][Full Text] [Related]
54. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
[No Abstract] [Full Text] [Related]
55. Brain tumor imaging with synthesized 18F-fluorophenylalanine and positron emission tomography.
Mineura K; Kowada M; Shishido F
Surg Neurol; 1989 Jun; 31(6):468-9. PubMed ID: 2718089
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
57. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
58. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
59. Prediction of survival in glioma patients by means of positron emission tomography.
Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
[TBL] [Abstract][Full Text] [Related]
60. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
